Cargando…

Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics

Introduction—Recovery from peripheral nerve injuries is poor even though injured peripheral axons can regenerate. Novel therapeutic approaches are needed. The most successful preclinical experimental treatments have relied on increasing the activity of the regenerating axons, but the approaches take...

Descripción completa

Detalles Bibliográficos
Autores principales: Ecanow, Anna, Berglund, Ken, Carrasco, Dario, Isaacson, Robin, English, Arthur W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783325/
https://www.ncbi.nlm.nih.gov/pubmed/36555724
http://dx.doi.org/10.3390/ijms232416084
_version_ 1784857551588818944
author Ecanow, Anna
Berglund, Ken
Carrasco, Dario
Isaacson, Robin
English, Arthur W.
author_facet Ecanow, Anna
Berglund, Ken
Carrasco, Dario
Isaacson, Robin
English, Arthur W.
author_sort Ecanow, Anna
collection PubMed
description Introduction—Recovery from peripheral nerve injuries is poor even though injured peripheral axons can regenerate. Novel therapeutic approaches are needed. The most successful preclinical experimental treatments have relied on increasing the activity of the regenerating axons, but the approaches taken are not applicable to many nerve-injured patients. Bioluminescent optogenetics (BL-OG) is a novel method of increasing the excitation of neurons that might be similar to that found with activity-dependent experimental therapies. We investigated the use of BL-OG as an approach to promoting axon regeneration following peripheral nerve injury. Methods—BL-OG uses luminopsins, light-sensing ion channels (opsins) fused with a light-emitting luciferase. When exposed to a luciferase substrate, such as coelenterazine (CTZ), luminopsins expressed in neurons generate bioluminescence and produce excitation through their opsin component. Adeno-associated viral vectors encoding either an excitatory luminopsin (eLMO3) or a mutated form (R115A) that can generate bioluminescence but not excite neurons were injected into mouse sciatic nerves. After retrograde transport and viral transduction, nerves were cut and repaired by simple end-to-end anastomosis, and mice were treated with a single dose of CTZ. Results—Four weeks after nerve injury, compound muscle action potentials (M waves) recorded in response to sciatic nerve stimulation were more than fourfold larger in mice expressing the excitatory luminopsin than in controls expressing the mutant luminopsin. The number of motor and sensory neurons retrogradely labeled from reinnervated muscles in mice expressing eLMO3 was significantly greater than the number in mice expressing the R115A luminopsin and not significantly different from those in intact mice. When viral injection was delayed so that luminopsin expression was induced after nerve injury, a clinically relevant scenario, evoked M waves recorded from reinnervated muscles were significantly larger after injury in eLMO3-expressing mice. Conclusions—Treatment of peripheral nerve injuries using BL-OG has significant potential to enhance axon regeneration and promote functional recovery.
format Online
Article
Text
id pubmed-9783325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97833252022-12-24 Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics Ecanow, Anna Berglund, Ken Carrasco, Dario Isaacson, Robin English, Arthur W. Int J Mol Sci Article Introduction—Recovery from peripheral nerve injuries is poor even though injured peripheral axons can regenerate. Novel therapeutic approaches are needed. The most successful preclinical experimental treatments have relied on increasing the activity of the regenerating axons, but the approaches taken are not applicable to many nerve-injured patients. Bioluminescent optogenetics (BL-OG) is a novel method of increasing the excitation of neurons that might be similar to that found with activity-dependent experimental therapies. We investigated the use of BL-OG as an approach to promoting axon regeneration following peripheral nerve injury. Methods—BL-OG uses luminopsins, light-sensing ion channels (opsins) fused with a light-emitting luciferase. When exposed to a luciferase substrate, such as coelenterazine (CTZ), luminopsins expressed in neurons generate bioluminescence and produce excitation through their opsin component. Adeno-associated viral vectors encoding either an excitatory luminopsin (eLMO3) or a mutated form (R115A) that can generate bioluminescence but not excite neurons were injected into mouse sciatic nerves. After retrograde transport and viral transduction, nerves were cut and repaired by simple end-to-end anastomosis, and mice were treated with a single dose of CTZ. Results—Four weeks after nerve injury, compound muscle action potentials (M waves) recorded in response to sciatic nerve stimulation were more than fourfold larger in mice expressing the excitatory luminopsin than in controls expressing the mutant luminopsin. The number of motor and sensory neurons retrogradely labeled from reinnervated muscles in mice expressing eLMO3 was significantly greater than the number in mice expressing the R115A luminopsin and not significantly different from those in intact mice. When viral injection was delayed so that luminopsin expression was induced after nerve injury, a clinically relevant scenario, evoked M waves recorded from reinnervated muscles were significantly larger after injury in eLMO3-expressing mice. Conclusions—Treatment of peripheral nerve injuries using BL-OG has significant potential to enhance axon regeneration and promote functional recovery. MDPI 2022-12-16 /pmc/articles/PMC9783325/ /pubmed/36555724 http://dx.doi.org/10.3390/ijms232416084 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ecanow, Anna
Berglund, Ken
Carrasco, Dario
Isaacson, Robin
English, Arthur W.
Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics
title Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics
title_full Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics
title_fullStr Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics
title_full_unstemmed Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics
title_short Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics
title_sort enhancing motor and sensory axon regeneration after peripheral nerve injury using bioluminescent optogenetics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783325/
https://www.ncbi.nlm.nih.gov/pubmed/36555724
http://dx.doi.org/10.3390/ijms232416084
work_keys_str_mv AT ecanowanna enhancingmotorandsensoryaxonregenerationafterperipheralnerveinjuryusingbioluminescentoptogenetics
AT berglundken enhancingmotorandsensoryaxonregenerationafterperipheralnerveinjuryusingbioluminescentoptogenetics
AT carrascodario enhancingmotorandsensoryaxonregenerationafterperipheralnerveinjuryusingbioluminescentoptogenetics
AT isaacsonrobin enhancingmotorandsensoryaxonregenerationafterperipheralnerveinjuryusingbioluminescentoptogenetics
AT englisharthurw enhancingmotorandsensoryaxonregenerationafterperipheralnerveinjuryusingbioluminescentoptogenetics